The Food and Drug Administration last week released an internalreview of the agency's medical device approval process that tookdevice manufacturers to task for submitting sloppy product approvalapplications. The review concluded that the poor quality of
The Food and Drug Administration last week released an internalreview of the agency's medical device approval process that tookdevice manufacturers to task for submitting sloppy product approvalapplications. The review concluded that the poor quality of applicationsis a factor in the ongoing gridlock of device approvals.
The Committee on Clinical Review was formed last April to reviewthe adequacy of clinical studies submitted by manufacturers tosupport premarket approval applications, investigational deviceexemptions and 510(k) applications. The committee is commonlyknown as the Temple committee, after its co-chair, Office of DrugEvaluation I director Dr. Robert Temple.
According to the Temple committee's report, some of the slowdownin the approval process could be due to deficiencies in clinicaldata submitted by manufacturers, deficiencies that were seriousenough to impede the agency's ability to review device applications.
"Applications containing deficiencies of the kind seenby the committee can require (Center for Devices and RadiologicalHealth) reviewers to spend tremendous resources bringing an applicationto an approvable state, necessitating repeated requests for additionaldata and prolonging the review period," the report concluded.
The committee recommended that manufacturers and CDRH reviewerswork more closely when studies are designed. The committee alsosuggested that a set of guidelines for study design and analysisbe developed and that advisory committees be used to improve thequality of data used in device applications.
Although some of the Temple committee's recommendations werewelcomed by the Health Industry Manufacturers Association, thedevice manufacturer group pointed out that the review was basedon an examination of only 29 applications out of the 5000 theagency reviews in a year.
BRIEFLY NOTED:
Previously, GE had agreed to sell the Advanced NMR InstaScanecho-planar imaging product for use with the 1.5-tesla Signa MRIsystem and promised customers an upgrade path to future GE-developedEPI products (SCAN 12/16/92).
As part of the new agreement, GE guarantees Advanced NMR thatit will buy 100 InstaScan systems or other Advanced NMR productsby the end of next year, with delivery by the end of 1995. Thetwo companies also agreed to cooperate in future MRI-related productdevelopment.
Meanwhile Lorad nabbed a major mammography contract with theU.S. army. The Danbury, CT, subsidiary of Thermo Electron willsupply mammography and stereotactic-guided biopsy equipment foreight army hospitals. Lorad values the contract at over $1 million.It will be completed this year.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.